--2025/Q1-- / 0.000--
--2024/Q4-- / 245.000K--
--2024/Q33.419M / 200.000K--
--2024/Q2181.800K / 300.000K--
--2024/Q1305.720K / 400.000K--
Microsoft
MSFT
D.R. Horton
DHI
Toll Brothers
TOL
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
ENSC Ensysce Biosciences
- 7.8245
- -0.3755-4.58%
Trading Jan 8 10:34 ET
10.21MMarket Cap-0.27P/E (TTM)
8.2300High7.5000Low24.67KVolume8.2200Open8.2000Pre Close194.37KTurnover2.56%Turnover RatioLossP/E (Static)1.30MShares30.900052wk High1.48P/B7.55MFloat Cap2.118052wk Low--Dividend TTM965.13KShs Float86364.0000Historical High--Div YieldTTM8.90%Amplitude2.1150Historical Low7.8780Avg Price1Lot Size
Ensysce Biosciences Key Stats
Ensysce Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Ensysce Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.